View Filing Data

5,153,898

5,253,579

6,141,030

900,000

Forfeited and Expired

44,201

20,558

25,858

^[1]

139,388

79,123

861,593

5,870,309

5,153,898

5,253,579

4,905,559

4,614,148

4,258,441

Weighted average exercise price

$ 3.951

$ 3.923

$ 3.563

2.370

Forfeited and Expired

6.833

6.603

4.372

^[1]

0.446

1.418

1.346

3.770

3.951

3.923

Intrinsic value of options exercised

$ 3.933

$ 3.591

$ 3.201

$ 447,000

$ 306,000

$ 4,800,000

Cash proceeds from exercise of options

$ 39,000

Common stock issued

133,930

[1]	(*) The total intrinsic value of options exercised during the years ended December 31, 2012, 2013 and 2014, was approximately $4.8 million, $306,000 and $447,000, respectively.

SHARE CAPITAL (Restricted Stock Granted to Employees) (Details) - Restricted Stock [Member] - shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Forfeited	185,709	17,834	3,208
Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding at beginning of year	970,208	1,394,708
Granted			1,500,000
Vested	398,375	406,666	102,084
Forfeited	185,709	17,834	3,208
Outstanding at end of year	386,124	970,208	1,394,708

SHARE CAPITAL (Options and Restricted Stocks Granted to Consultants, Directors and Other Service Providers) (Details) - Options and Restricted Stocks Granted To Consultants Directors And Other Service Providers [Member] - USD ($)
$ / shares in Units, $ in Millions

12 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Number of options

912,425

1,238,692

296,167

^[1]

326,267

1,208,592

912,425

912,425

Weighted average exercise price

$ 7.259

$ 5.385

2.678

^[1]

0.12

6.136

7.259

Intrinsic value of options exercised

$ 7.259

$ 2.3

[1]	(*) The total intrinsic value of options exercised during the year ended December 31, 2012 was approximately $2.3 million.

SHARE CAPITAL (Summary of Outstanding and Restricted Stocks) (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2014 USD ($) $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Options and restricted stock outstanding at end of year	7,465,025
Number of options exercisable at end of year	5,817,984
Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Options and restricted stock outstanding at end of year	490,624
Aggregate intrinsic value of the total vested and exercisable options \| $	$ 3.6
Aggregate intrinsic value of total outstanding options and restricted stock \| $	$ 2.7
0.001 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 0.001
Number of Options and restricted stock outstanding at end of year	719,207
Weighted average remaining contractual life	6 months 14 days
Number of options exercisable at end of year	719,207
Weighted average remaining contractual life, exercisable	6 months 14 days
0.120 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 0.120
Number of Options and restricted stock outstanding at end of year	308,801
Weighted average remaining contractual life	2 years
Number of options exercisable at end of year	308,801
Weighted average remaining contractual life, exercisable	2 years
0.972 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 0.972
Number of Options and restricted stock outstanding at end of year	995,853
Weighted average remaining contractual life	1 year 5 months 8 days
Number of options exercisable at end of year	995,853
Weighted average remaining contractual life, exercisable	1 year 5 months 8 days
2.350 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 2.350
Number of Options and restricted stock outstanding at end of year	40,000
Weighted average remaining contractual life	3 years 9 months 25 days
Number of options exercisable at end of year	40,000
Weighted average remaining contractual life, exercisable	3 years 9 months 25 days
2.370 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 2.370
Number of Options and restricted stock outstanding at end of year	900,000
Weighted average remaining contractual life	9 years 9 months
Number of options exercisable at end of year	56,250
Weighted average remaining contractual life, exercisable	9 years 9 months
2.650 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 2.650
Number of Options and restricted stock outstanding at end of year	345,082
Weighted average remaining contractual life	3 years 5 months 26 days
Number of options exercisable at end of year	345,082
Weighted average remaining contractual life, exercisable	3 years 5 months 26 days
3.020 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 3.020
Number of Options and restricted stock outstanding at end of year	50,000
Weighted average remaining contractual life	3 years 1 month 6 days
Number of options exercisable at end of year	50,000
Weighted average remaining contractual life, exercisable	3 years 1 month 6 days
3.370 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 3.370
Number of Options and restricted stock outstanding at end of year	150,000
Weighted average remaining contractual life	9 years 6 months 22 days
Number of options exercisable at end of year
Weighted average remaining contractual life, exercisable	9 years 6 months 22 days
5.000 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 5.000
Number of Options and restricted stock outstanding at end of year	1,708,000
Weighted average remaining contractual life	2 years 7 months 28 days
Number of options exercisable at end of year	1,708,000
Weighted average remaining contractual life, exercisable	2 years 7 months 28 days
6.810 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 6.810
Number of Options and restricted stock outstanding at end of year	150,000
Weighted average remaining contractual life	5 years 1 month 6 days
Number of options exercisable at end of year	150,000
Weighted average remaining contractual life, exercisable	5 years 1 month 6 days
6.900 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 6.900
Number of Options and restricted stock outstanding at end of year	991,916
Weighted average remaining contractual life	4 years 3 months 25 days
Number of options exercisable at end of year	829,249
Weighted average remaining contractual life, exercisable	4 years 3 months 25 days
7.550 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 7.550
Number of Options and restricted stock outstanding at end of year	160,000
Weighted average remaining contractual life	5 years 7 months 28 days
Number of options exercisable at end of year	160,000
Weighted average remaining contractual life, exercisable	5 years 7 months 28 days
9.660 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 9.660
Number of Options and restricted stock outstanding at end of year	68,000
Weighted average remaining contractual life	5 years 9 months 29 days
Number of options exercisable at end of year	68,000
Weighted average remaining contractual life, exercisable	5 years 9 months 29 days
16.700 [Member] \| Options And Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price \| $ / shares	$ 16.700
Number of Options and restricted stock outstanding at end of year	387,542
Weighted average remaining contractual life	1 year 11 months 26 days
Number of options exercisable at end of year	387,542
Weighted average remaining contractual life, exercisable	1 year 11 months 26 days

SHARE CAPITAL (Share Based Compensation Expense Allocation) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense	$ 1,242	$ 4,089	$ 7,751
Cost of Revenues [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense			220
Research and Development Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense	936	2,655	4,756
Marketing, General and administrative expenses [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated Share-based Compensation Expense	$ 306	$ 1,434	$ 2,775

CONVERTIBLE NOTES (Narrative) (Details) - USD ($)		12 Months Ended
CONVERTIBLE NOTES (Narrative) (Details) - USD ($)	Sep. 18, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CONVERTIBLE NOTES [Abstract]
Principal amount	$ 69,000,000
Principal amount, related to the initial purchaser's over-allotment option	$ 9,000,000
Interest rate	4.50%
Base value for conversion rate	$ 1,000
Number of shares for basis conversion	173.6593
Conversion price per share	$ 5.76
Net proceeds from issuance of convertible notes	$ 66,800,000		$ 66,780,000
Maturity	Sep. 15, 2018

CONVERTIBLE NOTES (Schedule of Interest Expense Recognized) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
CONVERTIBLE NOTES [Abstract]
Contractual interest expense	$ 3,105	$ 888
Amortization of debt issuance costs and debt discount	444	127
Total	$ 3,549	$ 1,015

FAIR VALUE MEASUREMENT (Details) $ in Millions	Dec. 31, 2014 USD ($)
FAIR VALUE MEASUREMENT [Abstract]
Fair value convertible notes	$ 52.4

TAXES ON INCOME (Narrative) (Details) $ in Millions	12 Months Ended
TAXES ON INCOME (Narrative) (Details) $ in Millions	Dec. 31, 2014 USD ($)
Income Tax Disclosure [Line Items]
Withholding tax on the U.S. revenue source portion of the payments made to the Company for its share of Pfizer's net profits	15.00%
Net operating loss carry forwards	$ 138.8
Restricted Amount [Member]
Income Tax Disclosure [Line Items]
Net operating loss carry forwards	$ 16.9
Protalix Ltd. [Member]
Income Tax Disclosure [Line Items]
Statutory income tax rate	39.00%
Additional tax rate, 2012	25.00%
Additional tax rate, 2013	25.00%
Additional tax rate, 2014 and thereafter	26.50%
Net operating loss carry forwards	$ 121.9

TAXES ON INCOME (Deferred Income Taxes) (Details) - USD ($) $ in Thousands	Dec. 31, 2014	Dec. 31, 2013
TAXES ON INCOME [Abstract]
Research and development expenses	$ 3,136	$ 5,257
Property and equipment	(372)	(491)
Provision for vacation	374	417
Severance pay obligation	185	209
Deferred revenues	8,658	9,867
Net operating loss carry forwards	28,130	23,167
Valuation allowance	(40,111)	(38,426)
Deferred Tax Assets, Net of Valuation Allowance, Total

TAXES ON INCOME (Open Tax Years) (Details)

12 Months Ended

Dec. 31, 2014

ISRAEL [Member] | Minimum [Member]

ISRAEL [Member] | Maximum [Member]

2011

UNITED STATES [Member] | Minimum [Member]

2014

UNITED STATES [Member] | Maximum [Member]

2010

^[1]